Please Wait.....
Report
Indonesia In-Vitro Diagnostics Market Research Report Forecast to 2027
Market Report I 2022-09-27 I 82 Pages I Market Research Future
Indonesia In-Vitro Diagnostics Market Research Report Forecast to 2027
Market OVERVIEW
In-vitro diagnostics (IVD) are medical devices, reagents, and accessories used to perform tests on samples, (e.g., blood, urine, and tissue) taken from the human body to help detect infection, diagnose a medical condition, and prevent disease. IVD plays a major role in the early diagnosis and management of diseases. The key factors that drive the Indonesia in-vitro diagnostics market are rising prevalence of chronic & infectious diseases and growing awareness of personalized medicine. However, an unfavorable reimbursement scenario is anticipated to hamper the market growth.
In-vitro diagnostics (IVDs) are non-invasive tests performed on biological samples (for example, blood, urine, or tissues) to diagnose a disease. IVDs provide valuable information on the body's functioning and state of health. IVD is used for the diagnosis, screening, and therapeutic monitoring of diseases. IVDs have a broad scope ranging from sophisticated technologies performed in clinical laboratories to simple self-tests, such as those for pregnancy and glucose monitoring.
The Indonesia in-vitro diagnostics market is emerging due to the high prevalence of chronic and infectious diseases, increasing adoption of point-of-care testing, and rising collaborations between private and public organizations for the development of the healthcare sector are responsible for the growth of the Indonesia in-vitro diagnostics market. However, regulatory procedures for high/moderate-complexity tests and information and interest gap between investors and developers are likely to restrain the market growth during the forecast period. The scope of the Indonesia in-vitro diagnostics market study includes market size analysis and a detailed analysis of the manufacturer's products and service strategies.
Market Segmentation
The market has been segmented based on product & services, technology, application and end user.
The Indonesia in-vitro diagnostics market is segmented on the basis of product & services into reagents & kits, instruments, data management, and software & services. The instruments segment is further segmented into fully automated instruments and semi-automated instruments.
The Indonesia in-vitro diagnostics market is segmented on the basis of technology into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, hemostasis, hematology, and others. The others segment includes microbiology and tissue diagnostics.
Based on application, the Indonesia in-vitro diagnostics market is bifurcated into infectious diseases oncology, cardiology, autoimmune diseases, nephrology, diabetes, HIV-AIDS, drug testing, and pharmacogenomics.
Based on end user, the Indonesia in-vitro diagnostics market is segmented into hospitals, laboratories, point-of-care testing, academic institutes, and others.
Major Players
The key players of the Indonesia in-vitro diagnostics market are BD, Bio-rad Laboratories, Thermo Fisher Scientific, Biomeruix SA, and Danaher Corporation.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 HIGH PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
4.2.2 INCREASING ADOPTION OF POINT-OF-CARE TESTING
4.2.3 RISING COLLABORATIONS BETWEEN PRIVATE AND PUBLIC ORGANIZATIONS FOR THE DEVELOPMENT OF THE HEALTHCARE SECTOR
4.3 RESTRAINTS
4.3.1 REGULATORY PROCEDURES FOR HIGH/MODERATE-COMPLEXITY TESTS
4.3.2 INFORMATION AND INTEREST GAP BETWEEN INVESTORS AND DEVELOPERS
4.4 OPPORTUNITY
4.4.1 GROWING SIGNIFICANCE OF COMPANION DIAGNOSTICS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE INDONESIA IN-VITRO DIAGNOSTICS MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON MARKET
5.3.3 IMPACT ON R&D
6 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.3 INSTRUMENTS
6.4 DATA MANAGEMENT
6.5 SOFTWARE & SERVICES
7 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 IMMUNOASSAY/IMMUNOCHEMISTRY
7.3 CLINICAL CHEMISTRY
7.4 MOLECULAR DIAGNOSTICS
7.5 HEMOSTASIS
7.6 HEMATOLOGY
7.7 OTHERS
8 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 INFECTIOUS DISEASES
8.3 DIABETES
8.4 ONCOLOGY
8.5 CARDIOLOGY
8.6 AUTOIMMUNE DISEASES
8.7 HIV/AIDS
8.8 DRUG TESTING
8.9 NEPHROLOGY
8.10 PHARMACOGENOMICS
8.11 OTHERS
9 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.3 LABORATORIES
9.4 POINT-OF-CARE TESTING
9.5 ACADEMIC INSTITUTES
9.6 OTHERS
10 COMPETITIVE LANDSCAPE
10.1 COMPETITIVE OVERVIEW
10.2 MAJOR PLAYERS IN THE INDONESIA IN-VITRO DIAGNOSTICS MARKET
10.3 COMPETITIVE BENCHMARKING
10.4 MAJOR PLAYERS FINANCIAL MATRIX
10.4.1 REVENUE OF MAJOR PLAYERS, 2020
10.4.2 R&D EXPENDITURE, 2020
11 COMPANY PROFILES
11.1 F. HOFFMANN-LA ROCHE LTD
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS/SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 SYSMEX CORPORATION
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS/SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIES
11.3 DANAHER CORPORATION
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 BIO-RAD LABORATORIES, INC.
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS/SERVICES OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 BIOMERIEUX SA
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS/SERVICES OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 BECTON, DICKINSON AND COMPANY
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS/SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 SIEMENS
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS/SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 THERMO FISHER SCIENTIFIC, INC.
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 QIAGEN
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 AGILENT TECHNOLOGIES
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2018-2027 (USD MILLION)
TABLE 4 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY REAGENTS & KITS, 2018-2027 (USD MILLION)
TABLE 5 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY INSTRUMENTS, 2018-2027 (USD MILLION)
TABLE 6 INDONESIA IN-VITRO DIAGNOSTICS MARKET, FOR INSTRUMENTS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 7 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY DATA MANAGEMENT, 2018-2027 (USD MILLION)
TABLE 8 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY SOFTWARE & SERVICES, 2018-2027 (USD MILLION)
TABLE 9 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 10 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY IMMUNOASSAY/IMMUNOCHEMISTRY, 2018-2027 (USD MILLION)
TABLE 11 INDONESIA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY, BY TYPE, 2018-2027 (USD MILLION)
TABLE 12 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY CLINICAL CHEMISTRY, 2018-2027 (USD MILLION)
TABLE 13 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2018-2027 (USD MILLION)
TABLE 14 INDONESIA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2018-2027 (USD MILLION)
TABLE 15 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY HEMOSTASIS, 2018-2027 (USD MILLION)
TABLE 16 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY HEMATOLOGY, 2018-2027 (USD MILLION)
TABLE 17 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY OTHERS, 2018-2027 (USD MILLION)
TABLE 18 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 19 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
TABLE 20 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY DIABETES, 2018-2027 (USD MILLION)
TABLE 21 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY DIABETES, 2018-2027 (USD MILLION)
TABLE 22 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY CARDIOLOGY, 2018-2027 (USD MILLION)
TABLE 23 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY AUTOIMMUNE DISEASES, 2018-2027 (USD MILLION)
TABLE 24 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY HIV/AIDS, 2018-2027 (USD MILLION)
TABLE 25 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY DRUG TESTING, 2018-2027 (USD MILLION)
TABLE 26 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY NEPHROLOGY, 2018-2027 (USD MILLION)
TABLE 27 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY PHARMACOGENOMICS, 2018-2027 (USD MILLION)
TABLE 28 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY OTHERS, 2018-2027 (USD MILLION)
TABLE 29 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 30 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 31 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY LABORATORIES, 2018-2027 (USD MILLION)
TABLE 32 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2018-2027 (USD MILLION)
TABLE 33 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY ACADEMIC INSTITUTES, 2018-2027 (USD MILLION)
TABLE 34 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY OTHERS, 2018-2027 (USD MILLION)
TABLE 35 MAJOR PLAYERS IN THE INDONESIA IN-VITRO DIAGNOSTICS MARKET
TABLE 36 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED
TABLE 37 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 38 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 39 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 40 BIOMERIEUX SA: PRODUCTS/SERVICES OFFERED
TABLE 41 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED
TABLE 42 SIEMENS: PRODUCTS/SERVICES OFFERED
TABLE 43 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 44 QIAGEN: PRODUCTS/SERVICES OFFERED
TABLE 45 AGILENT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED
FIGURE 1 MARKET SYNOPSIS 11
FIGURE 2 MARKET STRUCTURE: INDONESIA IN-VITRO DIAGNOSTICS MARKET 12
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 19
FIGURE 4 MARKET DYNAMICS: INDONESIA IN-VITRO DIAGNOSTICS MARKET 22
FIGURE 5 VALUE CHAIN ANALYSIS: INDONESIA IN-VITRO DIAGNOSTICS MARKET 27
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: INDONESIA IN-VITRO DIAGNOSTICS MARKET 29
FIGURE 7 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2020 & 2027 (USD MILLION) 32
FIGURE 8 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 & 2027 (USD MILLION) 35
FIGURE 9 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 41
FIGURE 10 INDONESIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2020 & 2027 (USD MILLION) 45
FIGURE 11 BENCHMARKING OF MAJOR COMPETITORS 49
FIGURE 12 REVENUE OF MAJOR PLAYERS, 2020 50
FIGURE 13 MAJOR PLAYERS R&D EXPENDITURE, 2020 50
FIGURE 14 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 52
FIGURE 15 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 53
FIGURE 16 SYSMEX CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 55
FIGURE 17 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 58
FIGURE 18 DANAHER CORPORATION: SWOT ANALYSIS 59
FIGURE 19 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 61
FIGURE 20 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS 62
FIGURE 21 BIOMERIEUX SA: FINANCIAL OVERVIEW SNAPSHOT 64
FIGURE 22 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 67
FIGURE 23 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS 68
FIGURE 24 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 70
FIGURE 25 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 73
FIGURE 26 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 74
FIGURE 27 QIAGEN: FINANCIAL OVERVIEW 76
FIGURE 28 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT 79
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security